COMMUNIQUÉS West-GlobeNewswire

Diffusion Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
09/05/2019
Enrollment in Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke to begin in Q3 CHARLOTTESVILLE, Va., May 09, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge [...]
Assembly Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights
09/05/2019
SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
BeiGene Reports First Quarter 2019 Financial Results
09/05/2019
CAMBRIDGE, Mass. and BEIJING, China, May 09, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Corcept Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update
09/05/2019
MENLO PARK, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Marrone Bio Innovations, Inc. Reports First-Quarter 2019 Financial Results
09/05/2019
First-Quarter 2019 Revenues More Than Doubled to $8.7 Million, with Gross Margins of 57 Percent DAVIS, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in [...]
Yield10 Bioscience Announces First Quarter 2019 Financial Results
09/05/2019
WOBURN, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Caladrius Biosciences Reports 2019 First Quarter Financial Results and Provides Corporate Update
09/05/2019
All enrolling clinical programs advancing with top-line data expected in late 2019 and during 1H2020 for CLBS14-CMD and CLBS12, respectively CLBS14-NORDA phase 3 program targeted to begin enrollment in late 2019 Cash on [...]
MyoKardia Reports First Quarter 2019 Financial Results
09/05/2019
Announces Enrollment Completing in the Phase 2 MAVERICK-HCM Trial Company to Host Conference Call and Webcast Today at 4:30 p.m. ET (1:30 p.m. PT) SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- MyoKardia [...]
Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline
09/05/2019
Continuing to execute commercial build and launch readiness for Gvoke HypoPen™ and Gvoke PFS ™ Dosed first patient in a Phase 2 study evaluating ready-to-use (RTU) glucagon in EIH Advancing diazepam to Phase 2 based on [...]
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
09/05/2019
Reports Net Revenues of $79.8 Million for the Three Months Ended March 31, 2019 RANCHO CUCAMONGA, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) [...]
The Joint Corp. Reports Preliminary First Quarter 2019 Financial Results
09/05/2019
- Increases System-Wide Gross Sales 32%, Compared to Q1 2018 - - Sells 30 Franchise Licenses, Up from 16 in Q1 2018 – - Opens 14 Clinics, 12 Franchised and 2 Greenfield, Compared to 7 Franchised Clinics in Q1 2018 - [...]
Adamas Reports First Quarter 2019 Financial Results
09/05/2019
- First quarter net product sales of $11.7 million - GOCOVRI® total prescriptions grew to approximately 5,820 in Q1 2019 - Phase 3 study of ADS-5102 (GOCOVRI) in walking impairment in patients with multiple sclerosis on [...]
Guardant Health Reports First Quarter 2019 Financial Results and Raises 2019 Revenue Guidance
09/05/2019
Q1 2019 revenue increase of 120% over prior year period and a substantial increase in gross margin REDWOOD CITY, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology [...]
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results
09/05/2019
Announces Initiation of Enrollment in Phase 1/1b Trial of ITK inhibitor CPI-818 Conference Call Today at 4:30 p.m. ET / 1:30 p.m. PT BURLINGAME, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. ( [...]
Principia Biopharma to Present at the 2019 Bank of America Merrill Lynch Health Care Conference
09/05/2019
SOUTH SAN FRANCISCO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Rockwell Medical, Inc. Reports First Quarter 2019 Financial Results
09/05/2019
Significant progress for portfolio of Triferic® therapeutics marked by launch of Dialysate Triferic WIXOM, Mich., May 09, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company [...]
ChromaDex Corporation Reports First Quarter 2019 Financial Results
09/05/2019
- First Quarter 2019 Net Revenues Increased by 53% to $10.0 Million - First Quarter 2019 Highlights vs. First Quarter 2018 Strong start to the year with $10.0 million of net sales, higher gross margins and increased [...]
TearLab Corporation Reports First Quarter 2019 Financial Results
09/05/2019
ESCONDIDO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the first quarter ended March 31, 2019. All dollar [...]
Osmotica Pharmaceuticals plc Reports First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
09/05/2019
First quarter 2019 total revenue of $57.1 million; net loss of $6.2 million Positive topline results from second Phase III clinical trials of RVL-1201 for ptosis or droopy eyelid BRIDGEWATER, N.J., May 09, 2019 (GLOBE [...]

Pages